H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program

Peter J. Leary, Edward Hess, Anna E. Barón, Kelley R. Branch, Gaurav Choudhary, Catherine L. Hough, Bradley A. Maron, David D. Ralph, John J. Ryan, Ryan Jm D. Tedford, Roham T. Zamanian, Tim Lahm, Richard L. Roudebush

Research output: Contribution to journalLetter

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)1638-1641
Number of pages4
JournalAmerican journal of respiratory and critical care medicine
Volume197
Issue number12
DOIs
StatePublished - Jun 15 2018
Externally publishedYes

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Leary, P. J., Hess, E., Barón, A. E., Branch, K. R., Choudhary, G., Hough, C. L., Maron, B. A., Ralph, D. D., Ryan, J. J., Tedford, R. J. D., Zamanian, R. T., Lahm, T., & Roudebush, R. L. (2018). H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program. American journal of respiratory and critical care medicine, 197(12), 1638-1641. https://doi.org/10.1164/rccm.201801-0048LE